HISTOMORPHOLOGICAL STUDY OF TRANSURETHRAL RESECTION OF PROSTATE SPECIMENS
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i2.50523Keywords:
Benign prostatic hyperplasia, TURP, Prostatic carcinoma, Molecular geneticsAbstract
Objectives: (The objectives of the study are as follows: 1) To study various histomorphological patterns of transurethral resection of prostate specimens. (2) To classify malignant lesions with Gleason’s grading and to do Prostate-specific antigen (PSA) level and immunohistochemistry as required.
Methods: It was a cross-sectional study conducted from January 2022 to June 2023 in a tertiary care hospital. Fifty-seven patients study who underwent transurethral resection of the prostate (TURP) surgery with hypertrophied prostate during the study period were included in the study on the basis of a predefined inclusion and exclusion criteria. Demographic characteristics of all the cases were analyzed. Clinical features, presenting complaints, histopathological findings, and the final diagnosis were studied. For statistical purposes, p value < 0.05 was taken as statistically significant.
Results: The majority of the participants were in the age group of 60–69 years (42.11%) followed by people in the age group of 70–79 years (35.09%). Benign disease of prostrate was common than the malignant disease. BHP was the most common disease encountered and was seen in 37 (64.91%) cases. Among 37 patients with BHP, 70.27% (26) patients had increased PSA levels. Among 10 patients of BHP with CP 8 (80%) patients had increased levels of PSA. Serum PSA levels were increased in all the cases of malignancy, Adenocarcinoma prostate and PIN.
Conclusion: In patients undergoing TURP modified Gleason scoring patterns and prognostic grade grouping should be done in conjunction for assessing prognosis and management. Immunohistochemistry and molecular genetic analysis are valuable adjuncts to the diagnosis in these cases.
Downloads
References
Crawford ED. Benign and malignant prostatic diseases. Am Fam Physician 1991;44:65S-70. PMID: 1950983
Humphrey PA. Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol 2004;17:292-306. doi: 10.1038/ modpathol.3 800054. PMID: 14976540
Lau HD, Clark M. Metastatic squamous cell carcinoma transformed from prostatic adenocarcinoma following androgen deprivation therapy: A case report with clinicopathologic and molecular findings. Diagn Cytopathol 2020;48:E14-7. doi: 10.1002/dc.24539. PMID: 32628337
St Sauver JL, Jacobsen SJ. Inflammatory mechanisms associated with prostatic inflammation and lower urinary tract symptoms. Curr Prostate Rep 2008;6:67-73. doi: 10.1007/s11918-008-0011-5. PMID: 19809538; PMCID: PMC2757322
Perera M, Lawrentschuk N, Perera N, Bolton D, Clouston D. Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years. Prostate Int 2016;4:11-4. doi: 10.1016/j. prnil.2015.10.016. PMID: 27014658; PMCID: PMC4789333
Puttaswamy K, Parthiban R, Shariff S. Histopathological study of prostatic biopsies in men with prostatism. J Med Sci Health 2016;2:11-7.
Sumaya, Das M, Nagesha KR. Spectrum of histopathological lesions of prostate in a tertiary care center. Int J Clin Diagn Pathol 2020;3:110-3. doi: 10.33545/pathol.2020.v3.i1b.163
Joshee A, Sharma KC. The histomorphological study of prostate lesions. IOSR J Dent Med Sci 2015;14:85-9.
Untergasser G, Madersbacher S, Berger P. Benign prostatic hyperplasia: Age-related tissue-remodeling. Exp Gerontol 2005;40:121-8. doi: 10.1016/j.exger.2004.12.008
Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P. Age at diagnosis and prostate cancer treatment and prognosis: A population-based cohort study. Ann Oncol 2018;29:377-85. doi: 10.1093/annonc/ mdx742
Yadav M, Desai H, Goswami H. Study of various histopathological patterns in prostate biopsy. Int J Curr Res Rev 2017;9:58-63.
Sharma A, Sharma M, Gandhi S, Khajuria A, Goswami KC. Histomorphological spectrum of prostatic lesions: A retrospective analysis of transurethral resection of prostate specimens. Int J Res Med Sci 2017;5:2373-8.
Gajjar H, Shah A, Parikh B, Shah J. Histopathological study of prostatic lesions. Indian J Appl Basic Med Sci 2020;22:446-52.
Maru AM, Makwana HH, Lakum NR, Chokshi T, Agnihotri A, Trivedi N, et al. Study on correlation between prostate specific antigen (PSA) and various prostatic pathology. Int J Med Sci Public Health 2014;3:735-7.
Sinha S, Siriguri SR, Kanakamedala SK, Bikkasani K. Prostate biopsy findings in Indian men: A hospital-based study. Indian J Cancer 2011;48:175-80.
Shah R, Karki S, Shah N, Dhakal S, Singh SK, Chaudhari RK. Histopathological study of prostatic diseases in B.P.K.I.H.S, Nepal: A hospital based study. Int J Health Sci Res 2019;9:77-83.
Kumar M, Khatri SL, Saxena V, Vijay S. Clinicopathological study of prostate lesions. Indian J Basic Appl Med Res 2016;6:695-704.
Krishnappa R, Soman S, Mysorekar VV, Kunnavil R, Reginalt SR. Clinicopathological evaluation of prostatic adenocarcinoma: A unicenter study. Ann Pathol Lab Med 2016;3:421-6.
Talukder SI, Roy MK, Azam MS, Huq MH, Haque MA, Saleh AF. Histopathological patterns of prostate specimens in Mymensingh. Dinajpur Med Coll J 2008;1:29-32.
Atchyuta M, Krishna P, Latha PP, Renuka IV, Tejaswini V, Vahini G, et al. Histopathological spectrum of prostatic adenocarcinoma in correlation with PSA Values. Indian J Pathol Oncol 2016;3:1-6.
Published
How to Cite
Issue
Section
Copyright (c) 2024 SUPARNA V SUVERNAKAR, DEEPAK SADHU, NITISH P INGOLE
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
